Tag Archives: Pfizer

Pfizer Inc. said a final analysis of data from clinical trials showed that its Covid-19 vaccine was 95% effective, paving the way for the company to apply for the first U.S. regulatory clearance for a vaccine against the coronavirus in a few days. US drugmaker and partner BioNTech SE said …

Pfizer Inc said Wednesday that a final analysis of clinical trial data showed that its Covid-19 vaccine was 95% effective, paving the way for the company to apply for the first U.S. regulatory clearance for a vaccine. against the coronavirus in a few days. US drugmaker and partner BioNTech SE …

Pfizer said no serious safety concerns related to the candidate vaccine have been reported. New Delhi: Major drugmaker Pfizer said Wednesday that its COVID-19 vaccine candidate was found to be 95 percent effective in the final analysis of the phase 3 trial, adding that it had the required two months …

The American biotechnology company Moderna announced on November 16 that its Covid vaccine is 94.5% effective. The US-German collaboration of Pfizer and BioNTech had previously made a similar announcement. These two “mRNA” vaccines are the most promising candidates undergoing phase 3 human trials now, and the vaccines could begin in …

Pfizer is “very close” to requesting an emergency use approval for its Covid-19 vaccine after collecting safety data to send to US regulators, the company’s chief executive said Tuesday, according to a report. Last week, Pfizer and its partner BioNTech SE reported that an interim analysis showed that their experimental …

NEW DELHI: India hopes that five locally tested vaccines will help control Covid-19, as those developed by Pfizer and Moderna may not be available in large quantities soon. The five candidates include Russia’s Sputnik-V, whose “Phase II going to Phase III” tests in India will begin next week in collaboration …

NEW DELHI: India is in dialogue with US biotech giant Moderna about progress in clinical trials of its coronavirus vaccine candidate, which the firm says has shown 94.5 percent efficacy, official sources said Monday. Moderna said Monday that the Data Safety Monitoring Board (DSMB) appointed by the independent National Institutes …

For the second time this month, more positive news comes from another Covid vaccine candidate. Moderna Inc today announced that the NIH-appointed Data Safety Monitoring Board (DSMB) for the Phase 3 study of mRNA-1273, its candidate vaccine against COVID-19, has shown that the company’s experimental vaccine is 94.5 % effective …

The new Covid vaccine being developed by Pfizer and BioNTech would begin delivery “late this year, early next year” if everything continues to go well, one of its creators said Sunday. Last week, BioNTech and co-developers Pfizer said preliminary analysis showed that their vaccine could prevent more than 90 percent …

Pfizer, Moderna, Novavax: executives from several US laboratories developing COVID-19 Vaccines have recently raked in millions of dollars by selling shares in their companies, raising questions about the advisability of such a move amid a national health crisis. On the same day that pharmaceutical giant Pfizer announced preliminary data showing …